Molecular genetic test for identifying cardiovascular disease risk factors and drug response markers. Enables personalized treatment strategies for heart disease management.
Manufactured by
China
YZY Medical is a high-tech enterprise specializing in personalized molecular diagnostics for cardiovascular and oncology applications. The company has developed 160+ genetic diagnostic products and multiple IVD devices, with 14 molecular diagnostic kits holding NMPA Class III registration. Technical platforms include ARMS qPCR, multiplex qPCR, mass spectrometry, FISH, and circulating tumor cell detection. The company operates a 2,000 sqm R&D center and 3,200 sqm GMP production facility with ISO13485:2016 and CE certifications.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Shanghai Chemtron Biotech Co.,Ltd.
China · 1 relevant product
Acon Biotech (Hangzhou) Co., Ltd.
China · 1 relevant product
Hipro Biotechnology Co., Ltd. CE CIBG
China · 1 relevant product
Shanghai Biotecan pharmaceuticals Co.,Ltd
China · 2 relevant products
Singlera GENOMICS (SHANGHAI) Ltd.
China · 1 relevant product
STRATEC/Diatron
Germany · 1 relevant product
BioChain (Beijing) Science & Technology. Inc.
China · 1 relevant product
Nanjing Synthgene Medical Technology Co., Ltd.
China · 2 relevant products
Eone-Diagnomics Genome Center
South Korea · 2 relevant products
Atom Scientific Ltd
United Kingdom · 1 relevant product
57 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →10 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 98 closest product alternatives
Shanghai Chemtron Biotech Co.,Ltd. · China
A diagnostic test designed to assess cardiovascular health and detect markers associated with heart disease and related conditions.
Acon Biotech (Hangzhou) Co., Ltd. · China
Molecular diagnostic test for inherited genetic disorder detection. Identifies mutations and genetic variations associated with hereditary diseases.
Hipro Biotechnology Co., Ltd. CE CIBG · China
Diagnostic reagent kit for cardiovascular disease markers and risk assessment. Detects biomarkers associated with cardiac dysfunction and heart disease.
Shanghai Biotecan pharmaceuticals Co.,Ltd · China
Precision medicine diagnostic test for cardiovascular disease screening and risk stratification. Incorporates genetic and molecular markers for personalized cardiovascular health management.
Singlera GENOMICS (SHANGHAI) Ltd. · China
A molecular diagnostic solution based on DNA methylation technology for identification and characterization of genetic diseases. Enables comprehensive genetic disease screening and diagnosis.
STRATEC/Diatron · Germany
Diagnostic test for identifying genetic disorders through molecular analysis of biological samples. The test can detect chromosomal abnormalities and inherited genetic conditions.
BioChain (Beijing) Science & Technology. Inc. · China
Epigenetic-based diagnostic test for early detection of cerebrovascular disease and stroke risk. Developed in collaboration with Beijing Tiantan Hospital, this test supports stroke prevention initiatives. The product integrates findings from a large-scale stroke cohort study.
Nanjing Synthgene Medical Technology Co., Ltd. · China
A diagnostic test for cardiac risk markers assessment in cardiovascular health evaluation. Detects biomarkers indicative of potential cardiac conditions.
Eone-Diagnomics Genome Center · South Korea
A genetic risk prediction test that assesses hereditary susceptibility to major cancers, general diseases, and ophthalmological conditions. It enables early personalized management and health planning based on genetic risk factors.
Atom Scientific Ltd · United Kingdom
PCR-based systems for genetic mutation and polymorphism detection. Supports pharmacogenomics and inherited disease diagnosis.
GMA Group Trading · Egypt
Genetic susceptibility testing for thrombophilia risk assessment using SNP analysis.
GenSure Biotech Inc. · China
Diagnostic test kit for measurement of biomarkers associated with cerebrovascular disease and stroke risk. Facilitates assessment of neurological and cerebrovascular health status.
86 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products